Biomarker Jeopardy

J Adv Pract Oncol. 2021 Apr;12(3):285-288. doi: 10.6004/jadpro.2021.12.3.13. Epub 2021 Apr 1.

Abstract

The popular Biomarker Jeopardy session returned this year at JADPRO Live 2020. Sandra E. Kurtin, PhD, ANP-C, AOCN®, led the session, and was joined by Alyssa Henglefelt, PharmD, BCOP, and Allyson Price, PA-C. Using a Jeopardy format, they identified specific biomarkers while discussing targeted therapies and class effects APs should be aware of.